SEC 13F Intelligence

Orion Investment Co / IOVA

Orion Investment Co’s Iovance Biotherapeutics Inc Position

Does Orion Investment Co own Iovance Biotherapeutics Inc (IOVA)? Yes — 2.07M shares worth $7M (+2.30% of its 13F portfolio) as of Q1 2026, up from 1.86M shares the prior filed quarter.

Position Value
$7M
Q1 2026
Shares
2.07M
% of Portfolio
+2.30%
Quarters Held
8
currently held

Position History IOVA

Reported value by quarter
Q2 ’24: $6MQ2 ’24Q3 ’24: $9MQ3 ’24Q4 ’24: $8MQ4 ’24Q1 ’25: $4MQ1 ’25Q2 ’25: $4MQ2 ’25Q3 ’25: $4MQ3 ’25Q4 ’25: $5MQ4 ’25Q1 ’26: $7MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.07M$7M+2.30%
Q4 20251.86M$5M+1.54%
Q3 20251.85M$4M+1.28%
Q2 20252.34M$4M+1.42%
Q1 20251.18M$4M+1.60%
Q4 20241.06M$8M+3.13%
Q3 2024906.3K$9M+3.31%
Q2 2024794.7K$6M+2.54%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orion Investment Co’s full portfolio or all institutional holders of IOVA.